Related Experiment Video For COVID-19
Updated: Jan 11, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Effects of the COVID-19 Pandemic on Patients with Tuberculosis
Sonay Gökçeoğlu1, Emine Beyaz2
1Şanlıurfa Provice Health Directorate, Şanlıurfa, Türkiye.
Objective:
People with tuberculosis (TB) are highly vulnerable to the coronavirus pandemic due to pre-existing lung damage, leading to a higher risk of complications from Coronavirus Disease 2019 (COVID-19). This study aims to examine the effects of the COVID-19 pandemic on patients with tuberculosis.
Materials And Methods:
A descriptive study was conducted with 101 TB patients between January and October 2021. Data analysis was performed using descriptive statistics (numbers, percentages), Fisher's Exact Test, Pearson's Chi-Squared Test, and multiple logistic regression.
Results:
Among the TB patients, 42.6% were negatively affected during the pandemic, while 57.4% were not affected. A total of 43.6% of patients received all COVID-19 vaccines. Factors including education level above primary school (65.9%), income level equal to or higher than expenses (71.4%), mask usage (61.5%), and a history of relapse or returning from treatment (100.0%) were significantly impacted by the pandemic. Logistic regression analysis revealed that mask usage increased the likelihood of being adversely affected by 3.0 times, while having an income equal to or greater than expenditures increased it by 4.5 times (p<0.05).
Conclusion:
With the positive influence of education, the demand for hospital and health services access increased among tuberculosis patients who experienced an improvement in their economic situation. However, even those who regularly used masks made mistakes in their usage. Consequently, these groups have been adversely affected during the COVID-19 pandemic.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

